畜牧兽医学报 ›› 2020, Vol. 51 ›› Issue (6): 1391-1398.doi: 10.11843/j.issn.0366-6964.2020.022

• 预防兽医 • 上一篇    下一篇

基因Ⅰ型乙型脑炎病毒病毒样颗粒的制备及其对小鼠的免疫原性分析

施磊1, 周亚红1, 田占成1*, 高闪电1, 独军政1, 关贵全1, 刘光远1, 罗建勋1, 殷宏1,2*   

  1. 1. 中国农业科学院 兰州兽医研究所 家畜疫病病原生物学国家重点实验室 甘肃省动物寄生虫病重点实验室, 兰州 730046;
    2. 江苏省动物重要疫病与人兽共患病防控协同创新中心, 扬州 225009
  • 收稿日期:2019-12-03 出版日期:2020-06-25 发布日期:2020-06-23
  • 通讯作者: 田占成,主要从事动物寄生虫与分子生物学研究,E-mail:tianzhancheng@caas.cn;殷宏,主要从事兽医微生物及其分子生物学研究,E-mail:yinhong@caas.cn
  • 作者简介:施磊(1980-),男,甘肃张掖人,硕士生,主要从事虫媒传播病毒分子病毒学研究,E-mail:1040717960@qq.com
  • 基金资助:
    国家自然科学基金项目(31201899);中国农业科学院农业科技创新工程项目(CAAS-ASTIP-2016-LVRI)

Generation of Genotype Ⅰ Japanese Encephalitis Virus Virus-like Particles and Evaluation of Its Immunogenicity in Mice

SHI Lei1, ZHOU Yahong1, TIAN Zhancheng1*, GAO Shandian1, DU Junzheng1, GUAN Guiquan1, LIU Guangyuan1, LUO Jianxun1, YIN Hong1,2*   

  1. 1. State Key Laboratory of Veterinary Etiological Biology/Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China;
    2. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China
  • Received:2019-12-03 Online:2020-06-25 Published:2020-06-23

摘要: 降低猪场的流行性乙型脑炎(Japanese encephalitis,JE)感染率对于阻断人的JE暴发至关重要,鉴于我国JE防控形势的紧迫性和现有基因Ⅲ型商品化乙型脑炎病毒疫苗对部分基因Ⅰ型乙型脑炎病毒(genotype Ⅰ Japanese encephalitis virus,GⅠ JEV)流行毒株免疫保护的不确定性,急需研制安全高效、成本低廉的新型猪用GI JEV疫苗。本研究在杆状病毒载体pFastBacTM多克隆酶切位点插入GⅠ JEV的prME基因表达盒,测序验证后的阳性重组质粒转染DH10BacTM感受态细胞后获得Bacmid-prME重组杆粒,进一步将其转染至Sf9昆虫细胞后,获得Bac-prME重组杆状病毒。Western blot、间接免疫荧光及电镜观察GⅠ JEV病毒样颗粒组成蛋白表达及病毒样颗粒形成情况,通过小鼠免疫试验初步评价GⅠ JEV病毒样颗粒的免疫原性。Sf9昆虫细胞中prME基因表达盒编码的蛋白得到高效表达,且组装形成病毒样颗粒。病毒样颗粒免疫原性评估结果表明:GⅠ JEV病毒样颗粒可诱导免疫小鼠产生高滴度的乙型脑炎病毒中和抗体。本研究利用杆状病毒昆虫细胞表达系统获得了GⅠ JEV病毒样颗粒,为研制安全高效的乙型脑炎病毒病毒样颗粒亚单位疫苗提供物质基础。

关键词: 乙型脑炎病毒, 杆状病毒, 病毒样颗粒, 免疫原性

Abstract: Decreasing the circulation of the Japanese encephalitis virus (JEV) in pigs is critical for blocking JEV infection in human. In view of the urgency of JE prevention and control in China and the uncertainty of the commercial Genotype Ⅲ JEV attenuated vaccine to the immuno-protection of partial Genotype Ⅰ JEV (GⅠ JEV) endemic strains, it is urgent to develop a safe, effective and low-cost GⅠ JEV vaccine for pigs. The expression cassette of JEV prME gene was cloned into the baculovirus shuttle vector to generate a recombinant bacmid (Bacmid-prME), the recombinant baculovirus was produced by transfecting Sf9 cells with Bacmid-prME. The accurate expression of the recombinant prME protein was confirmed by Western blot and immunofluorescence analysis, and the formation of Virus-Like Particles (VLPs) was verified through observing under Electronic microscopy. The immunogenicity of GⅠ JEV VLPs was further evaluated in mice. The recombinant prME protein was efficiently expressed in Sf9 cells and assembled into VLPs. GⅠ JEV VLPs induced the higher neutralizing antibody titer in mice. In our study, GⅠ JEV VLPs obtained in the baculovirus expression system provides a material basis for the development of a safe and effective JEV subunit vaccine.

Key words: Japanese encephalitis virus, baculovirus, virus-like particles, immunogenicity

中图分类号: